245 related articles for article (PubMed ID: 3285264)
1. Peritoneal cytology as an indicator of disease in patients with residual ovarian carcinoma.
Rubin SC; Dulaney ED; Markman M; Hoskins WJ; Saigo PE; Lewis JL
Obstet Gynecol; 1988 Jun; 71(6 Pt 1):851-3. PubMed ID: 3285264
[TBL] [Abstract][Full Text] [Related]
2. False-negative peritoneal cytology in metastatic ovarian carcinoma.
Pretorius RG; Lee KR; Papillo J; Baker S; Belinson J
Obstet Gynecol; 1986 Nov; 68(5):619-23. PubMed ID: 3763072
[TBL] [Abstract][Full Text] [Related]
3. CA 125 in peritoneal washings and fluid: correlation with plasma CA 125 and peritoneal cytology.
Schwartz PE; Chambers SK; Chambers JT; Tilton K; Foemmel R
Obstet Gynecol; 1989 Mar; 73(3 Pt 1):339-42. PubMed ID: 2915859
[TBL] [Abstract][Full Text] [Related]
4. Relationship between peritoneal washing cytology through implantable port system (IPS-cytology) and second-look laparotomy in ovarian cancer patients with unmeasurable residual diseases.
Fujiwara K; Yamauchi H; Yoshida T; Suzuki S; Oda T; Kohno I
Gynecol Oncol; 1998 Aug; 70(2):231-5. PubMed ID: 9740696
[TBL] [Abstract][Full Text] [Related]
5. Cytologic smears of peritoneal surfaces as a sampling technique in epithelial ovarian carcinoma.
Jadhon ME; Morgan MA; Kelsten ML; Carlson JA; Mikuta JJ
Obstet Gynecol; 1990 Jan; 75(1):102-5. PubMed ID: 2296407
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of cytologic peritoneal washings.
Willett GD
Clin Lab Med; 1985 Jun; 5(2):265-74. PubMed ID: 3896625
[TBL] [Abstract][Full Text] [Related]
7. Peritoneal washings in ovarian tumors. Potential sources of error in cytologic diagnosis.
Covell JL; Carry JB; Feldman PS
Acta Cytol; 1985; 29(3):310-6. PubMed ID: 3859128
[TBL] [Abstract][Full Text] [Related]
8. The significance of positive peritoneal cytology in endometrial cancer.
Sutton GP
Oncology (Williston Park); 1990 Jun; 4(6):21-6; discussion 30-2. PubMed ID: 2144998
[TBL] [Abstract][Full Text] [Related]
9. The prognostic significance of peritoneal seeding and size of postsurgical residual in patients with stage III epithelial ovarian cancer treated with surgery, chemotherapy, and high-dose radiotherapy.
Kapp KS; Kapp DS; Poschauko J; Stücklschweiger GF; Hackl A; Pickel H; Petru E; Winter R
Gynecol Oncol; 1999 Sep; 74(3):400-7. PubMed ID: 10479500
[TBL] [Abstract][Full Text] [Related]
10. Peritoneal cytology of ovarian cancer patients receiving intraperitoneal therapy: quantitation of malignant cells and response.
Sagae S; Berek JS; Fu YS; Chang N; Dauplat J; Hacker NF
Obstet Gynecol; 1988 Nov; 72(5):782-8. PubMed ID: 3173930
[TBL] [Abstract][Full Text] [Related]
11. The histologic subtype of ovarian tumors affects the detection rate by pelvic washings.
Fadare O; Mariappan MR; Wang S; Hileeto D; McAlpine J; Rimm DL
Cancer; 2004 Jun; 102(3):150-6. PubMed ID: 15211473
[TBL] [Abstract][Full Text] [Related]
12. Prospective comparative cytologic study of direct peritoneal smears and lavage fluids in patients with epithelial ovarian cancer and benign gynecologic disease.
Luesley DM; Williams DR; Ward K; Redman CR; Lawton FG
Acta Cytol; 1990; 34(4):539-44. PubMed ID: 2375222
[TBL] [Abstract][Full Text] [Related]
13. [Significance of intraoperatively obtained peritoneal cytology in malignant ovarian tumors].
Göppinger A; Hilgarth M; Pfleiderer A; Hillemanns HG
Geburtshilfe Frauenheilkd; 1986 Nov; 46(11):808-10. PubMed ID: 3803875
[TBL] [Abstract][Full Text] [Related]
14. Peritoneal cytology as an indicator of disease in patients with residual ovarian carcinoma.
McGowan L
Obstet Gynecol; 1989 Jan; 73(1):136-7. PubMed ID: 2909035
[No Abstract] [Full Text] [Related]
15. Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer.
Yabushita H; Shimazu M; Noguchi M; Kishida T; Narumiya H; Sawaguchi K; Noguchi M
Oncol Rep; 2003; 10(1):89-95. PubMed ID: 12469150
[TBL] [Abstract][Full Text] [Related]
16. Peritoneal washing cytology at second-look laparotomy in cisplatin-treated ovarian cancer patients.
Kudo R; Takashina T; Ito E; Mizuuchi H; Sagae S; Moriwaka O; Tamagawa A
Acta Cytol; 1990; 34(4):545-8. PubMed ID: 2375223
[TBL] [Abstract][Full Text] [Related]
17. Peritoneal fluid cytology and prognosis in patients with endometrial carcinoma.
Hirai Y; Fujimoto I; Yamauchi K; Hasumi K; Masubuchi K; Sano Y
Obstet Gynecol; 1989 Mar; 73(3 Pt 1):335-8. PubMed ID: 2915858
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of peritoneal cytology in patients with carcinoma of the uterine cervix.
Takeshima N; Katase K; Hirai Y; Yamawaki T; Yamauchi K; Hasumi K
Gynecol Oncol; 1997 Jan; 64(1):136-40. PubMed ID: 8995562
[TBL] [Abstract][Full Text] [Related]
19. Long-term prognostic value of conventional peritoneal lavage cytology in patients undergoing curative colorectal cancer resection.
Noura S; Ohue M; Seki Y; Yano M; Ishikawa O; Kameyama M
Dis Colon Rectum; 2009 Jul; 52(7):1312-20. PubMed ID: 19571710
[TBL] [Abstract][Full Text] [Related]
20. Cervicovaginal and endometrial cytology in ovarian cancer.
Takashina T; Ono M; Kanda Y; Sagae S; Hayakawa O; Ito E
Acta Cytol; 1988; 32(2):159-62. PubMed ID: 3348057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
